Skip to main content

Table 1 Demographic data of RTW group and non-RTW group

From: Investigation on returning to work in liver cancer survivors in Taiwan: a 5-year follow-up study

Variables RTW
(N = 1123)
Non-RTW
(N = 1328)
p value
Characteristic
Age (years) 50.5 ± 8.8 (23 ~ 81) 52.7 ± 9.5 (23 ~ 85) < 0.0001
Gender (male) 874 (77.8%) 1068 (80.4%) 0.1146
Comorbidities
Disorders of lipoid metabolism 100 (8.9%) 134 (10.1%) 0.3196
Alcohol abuse 39 (3.5%) 31 (2.3%) 0.0918
Hypertension 230 (20.5%) 303 (22.8%) 0.1626
Congestive heart failure 12 (1.1%) 21 (1.6%) 0.2724
Peripheral vascular disease 8 (0.7%) 15 (1.1%) 0.2859
Cerebrovascular disease 20 (1.8%) 39 (2.9%) 0.0629
Chronic pulmonary disease 53 (4.7%) 77 (5.8%) 0.2351
Rheumatologic disease 14 (1.2%) 10 (0.8%) 0.2162
Peptic ulcer disease 178 (15.9%) 241 (18.1%) 0.1323
Mild liver disease 704 (62.7%) 695 (52.3%) < 0.0001
Renal disease 42 (3.7%) 50 (3.8%) 0.974
Moderate or severe liver disease 37 (3.3%) 38 (2.9%) 0.5349
Depression 37 (3.3%) 37 (2.8%) 0.4635
Treatment
Operation 1100 (98.0%) 1260 (94.9%) < 0.0001
Radiation therapy 6 (0.5%) 33 (2.5%) 0.0001
Chemotherapy 67 (6.0%) 156 (11.7%) < 0.0001
Living area when diagnosed of cancer 0.5736
Central 227 (20.2%) 290 (21.8%)  
North 517 (46.0%) 626 (47.1%)  
East 20 (1.8%) 24 (18.2%)  
South 351 (31.3%) 382 (28.8%)  
Islands 8 (0.7%) 6 (0.5%)  
Income range (TWD)
  < 28,800 658 (58.6%) 691 (52.0%)  
28,800–38,200 205 (18.3%) 161 (12.1%)  
  > 38,200 260 (23.2) 476 (35.8%)  
Industrial classification 0.0585
Agriculture 97 (8.6%) 109 (8.2%)  
Manufacturing 360 (32.1%) 408 (30.7%)  
Electricity Supply 5 (0.4%) 18 (1.4%)  
Water Supply 7 (0.6%) 11 (0.8%)  
Construction 157 (14.0%) 188 (14.2%)  
Wholesale 117 (10.4%) 153 (11.5%)  
Transportation 111 (9.9%) 102 (7.7%)  
Food Service 33 (2.9%) 43 (3.2%)  
Information 22 (2.0%) 21 (1.6%)  
Financial 23 (2.0%) 28 (2.1%)  
Real Estate 9 (0.8%) 22 (1.7%)  
Technical Activities 22 (2.0%) 27 (2.0%)  
Support Service 21 (1.9%) 41 (3.1%)  
Public Administration 14 (1.2%) 25 (1.9%)  
Education 13 (1.2%) 17 (1.3%)  
Health Care 12 (1.1%) 22 (1.7%)  
Other Service 100 (8.9%) 93 (7.0%)  
Company size 0.0141
Shut down 89 (7.9%) 152 (11.4%)  
Small 80 (7.1%) 109 (8.2%)  
Medium 225 (20.0%) 265 (20.0%)  
Large 729 (64.9%) 802 (60.4%)  
Pathological Tumor stage < 0.0001
0,1 718 (63.9%) 503 (37.9%)  
2 276 (24.6%) 369 (27.8%)  
3 105 (9.3%) 359 (27.0%)  
4 24 (2.1%) 97 (7.3%)  
Pathological Node stage < 0.0001
0 1117 (99.5%) 1266 (95.3%)  
1 6 (0.5%) 62 (4.7%)  
Pathological Metastasis stage < 0.0001
0 1120 (99.7%) 1280 (96.4%)  
1 3 (0.3%) 48 (3.6%)  
Pathological stage < 0.0001
0,1 715 (63.7%) 495 (37.3%)  
2 274 (24.4%) 347 (26.1%)  
3 131 (11.7%) 438 (33.0%)  
4 3 (0.3%) 48 (3.6%)